1.
Prevalence of Cutaneous Adverse Drug Reactions According to Iraqi Pharmacovigilance Center; A retrospective study for 11 years (2010-2021) . AJPS. 2024;24(3):284-292. doi:10.32947/ajps.v24i3.1070